---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-011291"
form_type: "8-K"
ticker: "OLMA"
cik: "0001750284"
company_name: "Olema Pharmaceuticals, Inc."
filed_at: "2023-06-21T23:59:59+00:00"
generated_at: "2026-06-13T20:09:38.324810+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Olema holds annual meeting; stockholders elect three directors, approve say-on-pay, ratify E&Y auditor

## Summary
- Sean P. Bohen, Yi Larson, and Andrew Rappaport elected as Class III directors through 2026 with votes 23.5M, 18.0M, and 23.7M for respectively.
- Advisory vote on executive compensation approved: 18.7M for, 1.9M against, 5.0M abstain, 5.8M broker non-votes.
- Ratification of Ernst & Young as independent auditor for FY2023 approved: 30.9M for, 10k against, 540k abstain.
- Broker non-votes of 5.8M shares present on director and compensation proposals.

## SEC filing metadata
- accession: 0001558370-23-011291
- form_type: 8-K
- ticker: OLMA
- cik: 0001750284
- company_name: Olema Pharmaceuticals, Inc.
- filed_at: 2023-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/olma-20230615x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-011291
- JSON: https://secwatch.observer/filing/0001558370-23-011291.json
- Plain text: https://secwatch.observer/filing/0001558370-23-011291.txt

## Key facts
- Shareholder Votes
  Olema Pharmaceuticals, Inc. shareholders approved Ratification of Selection of Independent Registered Public Accounting Firm at the 2023-06-15 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Proposal 3— Ratification of Selection of Independent Registered Public Accounting Firm Final Voting Results For Against Abstain 30,921,828 ​ ​ 10,323 ​ ​ ​ 540,055
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm
- Shareholder Votes
  Olema Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-06-15 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Proposal 1— Election of Directors Final Voting Results Nominees For Withheld Broker Non-Votes Sean P. Bohen, M.D., Ph.D. 23,524,203 ​ ​ ​ 2,123,064 ​ ​ ​ 5,824,939 Yi Larson 17,980,507 ​ ​ ​ 7,666,760 ​ ​ ​ 5,824,939 Andrew Rappaport 23,727,247 ​ ​ ​ 1,920,020 ​ ​ ​ 5,824,939
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm
- Shareholder Votes
  Olema Pharmaceuticals, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2023-06-15 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-06-15
  source text: Proposal 2— Advisory Vote on Executive Compensation Final Voting Results For Against Abstain Broker Non-Votes 18,713,603 ​ ​ 1,912,571 ​ ​ ​ 5,021,093 ​ ​ ​ 5,824,939
  evidence_url: https://www.sec.gov/Archives/edgar/data/1750284/000155837023011291/0001558370-23-011291-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.